News
Public · Published
TEM: Q3 revenue rose 23%, led by oncology and data growth; FY guidance increased
Tempus AI reported that third-quarter revenue rose 23% to $411.5 million, with oncology volume up 32% and Data & Applications revenue growth of 33%. It increased its fiscal 2026 revenue guidance to $1.60 billion–$1.605 billion and expects about $65 million in adjusted EBITDA, a measure of operating earnings.
Published:
Updated:
What happened
Tempus AI reported that third-quarter revenue rose 23% to $411.5 million, with oncology volume up 32% and Data & Applications revenue growth of 33%. It increased its fiscal 2026 revenue guidance to $1.60 billion–$1.605 billion and expects about $65 million in adjusted EBITDA, a measure of operating earnings.
Confirmed
Global impact / market context
Faster oncology volume and Data & Applications growth could support higher revenue if those trends continue. The raised full-year forecast also signals greater expected sales, while the adjusted EBITDA outlook offers an indication of operating earnings; neither figure confirms how much cash the company will generate.
Analyst inference
The summary provides company growth rates and updated forecasts, but no share-price reaction, prior forecast figures, or outlook for peers. Investors therefore have limited context to judge whether the growth or guidance change is stronger than expected or how it compares with other businesses.
Analyst inference
What to watch
- Check later reports for oncology volume growth and Data & Applications growth; slowing in either could make it harder to meet the raised annual revenue forecast. Analyst inference
- Compare reported fiscal 2026 revenue with the $1.60 billion–$1.605 billion guidance range as results arrive; performance below it would show the forecast was not met. Analyst inference
- Track adjusted EBITDA against the expected roughly $65 million; this measure of operating earnings can help show whether revenue growth is accompanied by improving operating results. Analyst inference
Evidence
- Original source link unavailable